NicolePChappellMDFACOG, FACS(She/Her)

PubMed

• Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer-Accredited Facilities in the United St...
  Collin A Sitler, Chunqiao Tian, Chad A Hamilton, Michael T Richardson, John K Chan, Daniel S Kapp, Charles A Leath 3rd, Yovanni Casablanca, Christina Washington, Nicol...> ;Cancers. 2024 Mar 6
• 1 citations
  Analysis of Sociodemographic Factors Affecting Ambulatory Surgical Center Discharge Patterns for Endometrial Cancer Hysterectomies.
  Stephanie M Wang, Catherine Moore, Emma Keegan, Christopher Mayer, Ethan Litman, Kirsten J H Das, Catherine Z Wu, Nicole P Chappell> ;Journal of Minimally Invasive Gynecology. 2023 Nov 1
• Diagnostic Utility of Endocervical Curettage During Colposcopy Among Patients of Varying Risk Factors.
  Catherine Hoeppner, Emma Keegan, Logan Werner, Nicole P Chappell, Stephanie M Wang, Jamil Kazma> ;Journal of Lower Genital Tract Disease. 2022 Oct 1
• 1 citations
  Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncolog...
  Yovanni Casablanca, Guisong Wang, Heather A Lankes, Chunqiao Tian, Nicholas W Bateman, Caela R Miller, Nicole P Chappell, Laura J Havrilesky, Amy Hooks Wallace, Nilsa ...> ;Cancers. 2022 Aug 23
• 1 citations
  Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act.
  Rehema J Thomas, Destie Provenzano, Sharad Goyal, Murray Loew, Micael Lopez-Acevedo, Beverly Long, Nicole P Chappell, Yuan James Rao> ;Gynecologic Oncology. 2022 Jul 1
• 6 citations
  Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user
  William T. Jaegle, Jason C. Barnett, Bridget R. Stralka, Nicole P. Chappell> ;Gynecologic Oncology Reports. 2017 Oct 31
• 2 citations
  Actinomyces-Related Tubo-Ovarian Abscess in a Poorly Controlled Type II Diabetic With a Copper Intrauterine Device
  Ashley L. Sawtelle, Nicole P. Chappell, Caela R. Miller> ;Military Medicine. 2017 Mar 1
• 7 citations
  Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer?
  Nicole P. Chappell, Caela R. Miller, Aaron Fielden, Jason C. Barnett> ;Journal of Oncology Practice. 2016 May 31
• 9 citations
  Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GO...
  Caela R. Miller, Nicole P. Chappell, Caitlin Sledge, Charles A. Leath, Neil T. Phippen, Laura J. Havrilesky, Jason C. Barnett> ;Gynecologic Oncology. 2015 Apr 1
• 40 citations
  Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer.
  Nicole P. Chappell, Pang-ning Teng, Brian L. Hood, Guisong Wang, Kathleen M. Darcy, Chad A. Hamilton, G. Larry Maxwell, Thomas P. Conrads> ;Journal of Proteome Research. 2012 Sep 7
• Degenerating uterine myomas mimic ovarian dermoid cysts in a postmenopausal woman.
  Nicole P. Chappell, Liezl Grace Irisari> ;Journal of Minimally Invasive Gynecology. 2010 Nov 1
• Join now to see all

Journal Articles

• Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user  
  Jaegle WT, Barnett JC, Stralka BR, Chappell, NP, Gynecologic Oncology Reports, 1/31/2017
• Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GO...  
  Miller CR, Chappell NP, Sledge C, Leath CA 3rd, Phippen NT, Havrilesky LJ, Barnett JC, Gynecol Oncol, 1/1/2017
• Actinomyces-Related Tubo-Ovarian Abscess in a Poorly Controlled Type II Diabetic With a Copper Intrauterine Device  
  Sawtelle AL, Chappell NP, Miller CR, Mil Med, 1/1/2017
• Is FDA Approved Bevacizumab Cost-Effective in the Setting of Platinum-Resistant Recurrent Ovarian Cancer?  
  Chappell NP, Miller C, Barnett J, Fielden A, Obstet Gynecol, 1/1/2016
• Is FDA-approved Bevacizumab cost-effective when included in the treatment of platinum-resistant recurrent ovarian cancer?  
  Chappell NP, Miller CR, Fielden AD, Barnett JC, J Oncol Pract, 1/1/2016
• Degenerating Uterine Fibroids Mimic Ovarian Dermoid Cysts in a Postmenopausal Woman  
  Chappell, NP, Irisari I, J of Minim Invasive Gynecol, 1/1/2010
• Join now to see all

Abstracts/Posters

• Histology matters in developing a framework for explaining racial disparity in cervical cancer survival.
  Chappell NP, Rojas C, Casablanca G, Maxwell LG, Hamilton C, Darcy K, SGO Winter Meeting on Women's Cancer, Olympic Valley, CA, 1/1/2019
• Surgical Modalities and Differences in Outcome among Clinical Stage I Endometrial Cancer Patients in a Military Treatment Facility Compared to Civilian Hospitals.
  Cooper D, Chappell NP, Phippen N, Jaeger A, Annual District Meeting, Armed Forces District, ACOG, Honolulu, HI, 1/1/2018
• Right Atrial Thrombus During Cisplatin-based Combination Chemotherapy of Ovarian Yolk Sac Tumor: An Unusual Case Report.
  Jaeger A, Phippen N, Miller CR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Honolulu, HI, 1/1/2018
• Key Components for Implementation of a Structured Enhanced Recovery after Surgery (ERAS) Program at a Military Treatment Facility: a Novel Order Set and Multi-discipli...
  Chappell NP, Kallingal G, McKinlay A, Mielke RA, Saunders R, 2018 American College of Surgeons Quality and Safety Conference, Orlando, FL, 1/1/2018
• Quality Improvement and Patient Safety: A Faculty Development and Involvement Plan.
  Cox-Bauer CM, Keyser EA, Chappell NP, CREOG & APGO Meeting, National Harbor, MD, 1/1/2018
• Itchy Vulva: A Case of invasive vulvar melanoma.
  DeAssis V, Chappell NP, SAUSHEC Resident Research Day, San Antonio, TX, 1/1/2017
• Implementing ERAS: A pilot patient group in the department of Gynecology.
  Parson A, Storey J, DeAssis V, Shumbusho D, Chappell NP, SAUSHEC Patient Safety Week, San Antonio, TX, 1/1/2017
• Polypoid Endometriosis mimicking Invasive Cancer in an Obese, Postmenopausal Tamoxifen User.
  Jaegle TW, Barnett JC, McGovern BR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Case Study: Unusual presentation of Sertoli-Leydig cell ovarian tumor.
  Fett K, Miller CR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Acute Urinary Retention Leading to Diagnosis of Uterine Incarceration at 13 weeks.
  Sledge, C. Fielden A., Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Cervical Endometriosis Found During Treatment for Cervical Dysplasia.
  Wavers K, Miller CR, Chappell, NP, Annual District Meeting, Armed Forces District, ACOG, Orlando, FL, 1/1/2016
• Are different methotrexate regimens as first line therapy for low gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174.
  Miller CR., Chappell NP, Leath III CA., Phippen, NT, Havrilesky, LJ., Barnett, JC, Annual Meeting on Women's Cancer, Society of Gynecologic Oncology, Chicago, IL, 1/1/2015
• Coming Full Circle: Actinomyces related tubo-ovarian abscess in an immunosuppressed patient with a copper IUD.
  Sawtelle A, Chappell NP, Miller CR, Annual District Meeting, Armed Forces District, ACOG, Norfolk, VA, 1/1/2015
• Case report of an extra-gonadal retroperitoneal mature teratoma in a perimenopausal female.
  Wavers K, Simoni C, Chappell NP, Miller CR, Annual District Meeting, Armed Forces District, ACOG, Norfolk, VA, 1/1/2015
• Forniceal rupture secondary to a symptomatic fibroid uterus, a case report.
  Davila K, Miller CR, Chappell NP, Annual District Meeting, Armed Forces District, ACOG, Norfolk, VA, 1/1/2015
• Is FDA approved bevacizumab cost-effective when included in treatment of platinum-resistant recurrent ovarian cancer?
  Chappell NP, Miller CR, Fielden AD, Barnett JC, SAUSHEC Resident Research Day, San Antonio, TX, 1/1/2015
• Proteomic profiling of stage I endometrial cancers: an attempt to identify a signature of early stage recurrence in GOG 8016.
  Chappell NP, Mieznikowski J, Shepherd L, Ramirez, N, Wallace AH, Rose SG, Wang G, Hood BL, Casablanca, G, Berchuck A, Havrilesky L, Darcy K , Hamilton,CA, Conrads TP, ..., Annual Meeting on Women's Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/1/2014
• Proteomics-based Comparative Analysis of Mitochondria Isolated from Human Cisplatin-sensitive and Resistant Ovarian Carcinoma Cell Lines
  Chappell, NP, Teng, PN, Hood, B, Hamilton CA, Maxwell, GL, Conrads, TP, American Association for Cancer Research, Chicago, IL, 1/1/2012
• Mitochondrial Proteome in Cisplatin Resistant Ovarian Cancer Cell Lines.
  Chappell, NP, Conrads, TP, Teng PN, Hood, B. Maxwell GL, Annual District Meeting, Armed Forces District, ACOG, San Diego, CA, 1/1/2011
• Join now to see all

Lectures

• Key Components for Implementing an Enhanced Recovery After Surgery Program in Gynecologic Surgery at a Military Treatment Facility: Creation of a Novel Order Set and M... 
  Honolulu, HI - 1/1/2018
• Implementation of a Structured Enhanced Recovery after Surgery Program: Assessment of Surgical Quality Improvement Outcomes for Hysterectomy Procedures at a Military T... 
  Orlando, FL - 1/1/2018
• Is FDA Approved Bevacizumab cost-effective in the setting of platinum-resistant recurrent ovarian cancer? 
  Washington, DC - 1/1/2016
• The Molecular Basis of Estrogen-Dependent Disorders: A DNA study to Screen for Polymorphisms or Mutations Resulting in Estrogen Excess 
  Louisville, KY - 1/1/2008
• Join now to see all